Sutro

Sutro’s folate challenge to Immunogen hits a problem
EP Vantage
Fri, 01/7/22 - 10:29 am
Sutro
STRO-002
ovarian cancer
Second-quarter catalysts for the smaller players
EP Vantage
Wed, 04/7/21 - 10:25 am
AC Immune
Anavex
Santhera
IMMUTEP
Syndax
Novan
Fulcrum Therapeutics
BeyondSpring
Corbus
Orphazyme
Aldeyra
Adaptimmune
Inflarx
Sutro
Gemini Therapeutics
Eyeing an IPO, Sutro retools its $1B I/O deal with Celgene but stays focused on BCMA
Endpoints
Thu, 08/10/17 - 11:37 am
IPOs
Sutro
Celgene
BCMA
Celgene inks $500M-plus deal with ADC developer Sutro
Fierce Pharma
Wed, 12/19/12 - 01:35 pm
Celgene
Sutro
Pfizer, Sutro cut peptide drug deal
Bizjournals.com
Fri, 01/7/11 - 10:33 am
Pfizer
Sutro
peptides